Cagoco, Nenia .
HRN: 25-80-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/25/2024
10/02/2024
IV
500 Mg
Q8
PROM; Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes